{
    "root": "30c9d90b-eba6-17be-e063-6394a90a8408",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CHLORZOXAZONE",
    "value": "20250320",
    "ingredients": [
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "DOCUSATE SODIUM",
            "code": "F05Q2T2JA0"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CHLORZOXAZONE",
            "code": "H0DE420U8G"
        }
    ],
    "indications": "chlorzoxazone indicated adjunct rest , physical therapy , measures relief discomfort associated acute , painful musculoskeletal conditions . mode action clearly identified , may related sedative properties . chlorzoxazone directly relax tense skeletal muscles man .",
    "contraindications": "usual adult chlorzoxazone tablets 375 mg : one tablet three four times daily . adequate response obtained dose , 375 mg tablets may increased two tablets ( 750 mg ) three four times daily . improvement occurs usually reduced . chlorzoxazone tablets 500 mg : one tablet three four times daily . adequate response obtained dose , may increased one one-half tablets ( 750 mg ) three four times daily . improvement occurs usually reduced . chlorzoxazone tablets 750 mg : 1/3 tablet ( 250 mg ) three four times daily . initial painful musculoskeletal conditions 2/3 tablet ( 500 mg ) three four times daily . adequate response obtained dose , may increased one tablet ( 750 mg ) three four times daily . improvement occurs usually reduced .",
    "warningsAndPrecautions": "chlorzoxazone tablets , usp supplied follows : 500 mg white white capsule shaped tablet , debossed break line “ 1 2 ” one side plain side . bottle 30 tablets ndc : 80425-0507-01 bottle 60 tablets ndc : 80425-0507-02 bottle 90 tablets ndc : 80425-0507-03 dispense tight container defined official compendium . store 20° 25° c ( 68° 77° f ) [ usp controlled room temperature ] .",
    "adverseReactions": "chlorzoxazone contraindicated patients known intolerance .",
    "indications_original": "Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.",
    "contraindications_original": "Usual Adult Dosage\n                  \n                     Chlorzoxazone tablets 375 mg:\n                       One tablet three or four times daily. If adequate response is not obtained with this dose, the 375 mg tablets may be increased to two tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.\n\n \n                  \n                     Chlorzoxazone tablets 500 mg:\n                       One tablet three or four times daily. If adequate response is not obtained with this dose, it may be increased to one and one-half tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.\n\n \n                  \n                     Chlorzoxazone tablets 750 mg:\n                       1/3 tablet (250 mg) three or four times daily. Initial dosage for painful musculoskeletal conditions should be 2/3 tablet (500 mg) three or four times daily. If adequate response is not obtained with this dose, it may be increased to one tablet (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.",
    "warningsAndPrecautions_original": "Chlorzoxazone tablets, USP are supplied as follows:\n                  \n                     \n                        500 mg\n                     \n                  \n                  White to off white capsule shaped tablet, debossed with a break line between “1 and 2” on one side and plain on other side.\n                  \n                  Bottle of 30 Tablets NDC: 80425-0507-01\n                  Bottle of 60 Tablets NDC: 80425-0507-02\n                  \n                  Bottle of 90 Tablets NDC: 80425-0507-03\n                  \n                  \n                  Dispense in tight container as defined in the official compendium.\n  \n                     \nStore at 20° to 25° C (68° to 77° F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Chlorzoxazone is contraindicated in patients with known intolerance to the drug."
}